Approval · Notice of Compliance 3092 · 1998
PROSTEP: Notice of Compliance 3092
Issued June 1, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3092
- Date
- June 1, 1998
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Rx to otc switch
- Therapeutic class
- Smoking cessation aid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROSTEP | Not yet assigned | — |